Gevorg Tamamyan, the Editor-in-Chief of OncoDaily and the Head of the Pediatric Cancer and Blood Disorders Center of Armenia, posted on LinkedIn:

“Today we reached 5,000 followers on LinkedIn, but most importantly, already several months OncoDaily is ranked N1 by LinkedIn for organic content metrics in comparison to other 9 media channels GLOBALLY. And these 9 are not only oncology media channels, but also some of the largest global media platforms with millions of followers!

We don’t do advertisements, we don’t use bots, these are real people, majority are oncology specialists from all over the globe, presidents of cancer centers and societies, practicing oncologists and patient advocates, scientists and biotech/pharma people, nurses and policy makers. From all over the world!

This progress means people like what we are doing and it gives us a lot of motivation and inspiration! This is the work of a great team, who has made this progress in several months and we will continue to do more in the future! The best is yet to come! Thank you!”

Source: Gevorg Tamamyan/LinkedIn

Gevorg Tamamyan is the Editor-in-chief of OncoDaily, Head of the Pediatric Cancer and Blood Disorders Center of Armenia, Chairman and Professor of the Department of Hematology and Pediatric Oncology at Yerevan State Medical University, CEO of the Immune Oncology Research Institute, President-Elect of the Pediatric Oncology East and Mediterranean (POEM) Group. He is also the Adviser to the Rector of YSMU and to the Director of the Yeolyan Hematology and Oncology Center. He is a Co-Founder and Board Member of the Armenian Association of Hematology and Oncology, City of Smile Charitable Foundation, Co-Founder and Chairman of the Board of the Institute of Cancer and Crisis, the Former President of the Harvard Club of Armenia.

Dr. Tamamyan is the Past-Chair of the American Society of Clinical Oncology (ASCO) IDEA Steering Group and International Society of Pediatric Oncology (SIOP) PODC Supportive care WG, Ambassador of the Society of Hematologic Oncology. He was selected for the ASCO Leadership Development Program and currently is a member of the ASCO International Committee. He is a recipient of numerous awards and distinctions, among them the ASCO IDEA and LIFe Awards, 40 under 40 in Cancer Award, he was recognized as a Young Leader of the International Agency for Cancer Research (IARC) and Union for International Cancer Control (UICC). 

For more detailed information about Dr. Tamamyan, you can visit the Immune Oncology Research Institute’s website.